Clinical Trials Logo

Filter by:
NCT ID: NCT03859388 Active, not recruiting - Clinical trials for Kidney Transplant Rejection

Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

Start date: March 1, 2019
Phase:
Study type: Observational

Our group recently reported that tocilizumab, a humanized monoclonal antibody against the IL-6 receptor, may be effective when administered monthly to patients with chronic antibody-mediated rejection (ABMR). The current paradigm to assess response to therapy involves serial monitoring for donor-specific antibodies, measurement of kidney function with creatinine, and periodic kidney transplant biopsies to survey for histologic findings indicative of ongoing ABMR. A new non-invasive blood test, donor-derived cell-free DNA (Allosure) has recently reported to have a high degree of discrimination for rejection and may be used to assess the likelihood of rejection. It has not been tested to see if it can be used to assess treatment response for rejection. This study will assess longitudinal changes in donor-derived cell-free DNA measurements in response to monthly therapy with tocilizumab for chronic ABMR and correlate these measurements to histologic changes on a follow-up kidney transplant biopsy.

NCT ID: NCT03858322 Active, not recruiting - Breast Cancer Clinical Trials

'ADVANCE' (A Pilot Trial)

Start date: March 21, 2019
Phase: Phase 1
Study type: Interventional

This study is being conducted to carefully study how chemotherapy is tolerated in group of patients age 70.

NCT ID: NCT03858309 Active, not recruiting - CSF Circulation Clinical Trials

Influence of Yogic Breathwork on CSF Circulation

CSF
Start date: July 10, 2019
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine the influence of yoga breathing practices on cerebrospinal fluid (CSF) circulation, and to find out primarily if a regular practice of 8-week yoga breathing would enhance CSF circulation as well as if the intervention would improve participant's quality of life, quality of sleep, and reduce existing stress. Participants will be randomized into two arms for different breathing practices.

NCT ID: NCT03857620 Active, not recruiting - Carcinoma Clinical Trials

Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer

Start date: July 24, 2019
Phase: N/A
Study type: Interventional

This trial studies how well the use of a pre-surgical toolkit (OPTI-Surg) works in improving surgical care and outcomes in older participants with cancer. In many elderly patients, surgery can greatly affect physical condition and the ability to return to pre-surgery levels of physical functioning. Providing pre-surgical recommendations may help improve participants' recovery rate and functioning after surgery.

NCT ID: NCT03857321 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Study of Nasal Insulin to Fight Forgetfulness - Device Study

Start date: April 12, 2019
Phase: Phase 2
Study type: Interventional

The SNIFF Device study will involve using a device to administer insulin through each participant's nose or intra-nasally. Insulin is a hormone that is produced in the body. It works by lowering levels of glucose (sugar) in the blood. This study is measuring how much insulin the device delivers. In addition, this study will look at the effects of insulin or placebo administered intra-nasally using a nebulizer-like device on memory, blood, and cerebral spinal fluid.

NCT ID: NCT03856879 Active, not recruiting - COPD Clinical Trials

High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults

ACHIEVE
Start date: May 21, 2019
Phase: N/A
Study type: Interventional

This study examines an intervention to promote effective, evidence-based care and de-implement inappropriate therapies for COPD in HIV-infected (HIV+) patients. The intervention facilitates specialist support of primary care, which includes infectious disease (ID) physicians who serve as the primary care providers (PCP) for their HIV+ patients in the ID clinic. Rather than relying on referral-driven specialty care which may be a barrier to access, pulmonologists will proactively support ID providers to manage a population of HIV+ patients with COPD, delivering real-time evidence-based recommendations tailored to the individual HIV+ patient in the form of an E-consult.

NCT ID: NCT03856632 Active, not recruiting - Atrial Fibrillation Clinical Trials

Liraglutide Effect in Atrial Fibrillation

LEAF
Start date: March 18, 2019
Phase: Phase 4
Study type: Interventional

The goal (or purpose) of this study is to evaluate (study) a new way to stabilize (steady) the activity between the fat deposits surrounding the heart and the left atrium. To reduce the amount of EAT, this study will use a medication called Liraglutide. This medication is known to work on fat deposits and produce weight loss. The investigator is conducting this study to find out if Liraglutide will reduce the fat deposits surrounding the participant's heart, and stabilize (and perhaps reduce or eliminate) atrial fibrillation activity.

NCT ID: NCT03856086 Active, not recruiting - Cancer Caregivers Clinical Trials

Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients

Start date: February 25, 2019
Phase: N/A
Study type: Interventional

This study will help the researchers find out whether the S+C approach is better, the same as, or worse than EUC.

NCT ID: NCT03856060 Active, not recruiting - Malignant Neoplasm Clinical Trials

Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits

Start date: March 30, 2019
Phase: N/A
Study type: Interventional

This trial assesses patient perception of physician's compassion, communication skills, and professionalism during clinic visits through the use of videos and questionnaires.

NCT ID: NCT03855878 Active, not recruiting - Clinical trials for Monoclonal Gammopathy of Undetermined Significance

Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery

Start date: November 8, 2018
Phase:
Study type: Observational

Screening study to determine incidence of MGUS in this patient population